Watch for Dengue - the season has started

WHO Representative to Myanmar Dr S P Jost interviewed by media for awareness on dengue prevention and control. 5 June 2018

Dengue is one of the most common mosquitoborne viral infections which can be life-threatening. The dengue season just started in Myanmar. Hence, the time for advocacy and preparedness is perfect. The national Vector borne disease control programme organized advocacy meetings in states and regions, with support of WHO, during May and June 2018.

Handover of seasonal influenza vaccine to national health authorities (22 June 2018)

Credit: WHO Myanmar
Receiving seasonal flu vaccine by national health authorities at Yangon Regional Public Health Department

July to September is the usual influenza season in Myanmar coinciding with the monsoon. Seasonal influenza is a serious public health problem in every country. It can cause severe illness and death, especially in high risk populations. An influenza outbreak can take an economic toll, in lost productivity and strained health services.

Humanitarian assistance in Rakhine, Kachin and Shan States

MoHS mobile clinic supported by WHO and Central Emergency Response Fund in Maungdaw township, Rakhine State. 17 June 2018

Myanmar continues to face significant humanitarian challenges related to crisis in Rakhine State, armed conflicts in Kachin and northern Shan States and vulnerability to natural disasters. Ensuring effective humanitarian response in these areas remains a priority for WHO. WHO supports mobile medical teams of MoHS in Maungdaw, Buthidaung, Rathedaung and Sittwe townships of Rakhine State -- to provide life-saving health care to conflict affected people.

Hepatitis in Myanmar

Actor Lu Min and WHO Myanmar team call on to step up efforts to eliminate hepatitis by 2030. 11 June 2018

Among South-East Asia Region countries, Myanmar is the first country to provide hepatitis C treatment free of charge in the public sector. Three years after the National Hepatitis Control Programme was established, the hepatitis C treatment was started in seven public hospitals since 2017. To date, 2,089 patients were reported successfully treated by the programme.